SEC63 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.871200E-01
Normal-vs-Stage2
7.867000E-01
Normal-vs-Stage3
4.033200E-01
Normal-vs-Stage4
7.136800E-01
Stage1-vs-Stage2
7.285600E-01
Stage1-vs-Stage3
3.054600E-01
Stage1-vs-Stage4
7.146000E-01
Stage2-vs-Stage3
8.123300E-03
Stage2-vs-Stage4
4.485200E-01
Stage3-vs-Stage4
6.780200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.180600E-01
Normal-vs-AfricanAmerican
5.400600E-01
Normal-vs-Asian
4.572400E-01
Caucasian-vs-AfricanAmerican
1.023380E-01
Caucasian-vs-Asian
1.535170E-01
AfricanAmerican-vs-Asian
9.353500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.820600E-01
Normal-vs-Female
9.389200E-01
Male-vs-Female
4.139200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.263800E-01
Normal-vs-Age(41-60Yrs)
8.431600E-01
Normal-vs-Age(61-80Yrs)
7.415400E-01
Normal-vs-Age(81-100Yrs)
4.589000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.188200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.233000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.817800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.204400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.281620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.801800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.515400E-01
Normal-vs-Daily Drinker
1.711820E-01
Normal-vs-Weekly Drinker
5.120000E-01
Normal-vs-Occasional Drinker
8.632600E-01
Normal-vs-Social Drinker
9.017200E-01
Non Drinker-vs-Daily Drinker
1.775800E-01
Non Drinker-vs-Weekly Drinker
8.746000E-01
Non Drinker-vs-Occasional Drinker
1.462440E-01
Non Drinker-vs-Social Drinker
2.620400E-01
Daily Drinker-vs-Weekly Drinker
3.832800E-01
Daily Drinker-vs-Occasional Drinker
2.699800E-02
Daily Drinker-vs-Social Drinker
8.060300E-02
Weekly Drinker-vs-Occasional Drinker
1.948610E-01
Weekly Drinker-vs-Social Drinker
2.784200E-01
Occasional Drinker-vs-Social Drinker
9.661400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.673600E-02
Normal-vs-Grade 2
7.079700E-02
Normal-vs-Grade 3
6.414000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.875000E-01
Grade 1-vs-Grade 3
5.716400E-01
Grade 1-vs-Grade 4
9.673600E-02
Grade 2-vs-Grade 3
9.384400E-01
Grade 2-vs-Grade 4
7.079700E-02
Grade 3-vs-Grade 4
6.414000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.370000E-01
Normal-vs-NonDiabetic
6.539000E-01
Diabetic-vs-NonDiabetic
7.632800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.922200E-01
Normal-vs-NoPancreatitis
7.417000E-01
Pancreatitis-vs-NoPancreatitis
2.950800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.216000E-01
Normal-vs-N1
8.014400E-01
N0-vs-N1
6.784200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.622800E-01
Normal-vs-TP53-NonMutant
6.928600E-01
TP53-Mutant-vs-TP53-NonMutant
5.074500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
